Barclays Raises Price Target for Sartorius to 320 Euro

Barclays has increased its price target for Sartorius from 310 to 320 euros, while keeping an 'Overweight' rating. Analyst Charles Pitman-King indicated that Sartorius' third-quarter performance surpassed expectations, with particular strength noted in the Lab Products & Services division, which is capitalizing on the trend of AI-supported drug discovery.